INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $206,000 | -15.9% | 10,442 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $245,000 | -21.0% | 10,442 | -8.1% | 0.01% | -9.1% |
| Q4 2021 | $310,000 | +19.7% | 11,366 | +20.7% | 0.01% | +37.5% |
| Q3 2021 | $259,000 | -15.4% | 9,419 | -12.4% | 0.01% | +14.3% |
| Q2 2021 | $306,000 | -16.4% | 10,751 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $366,000 | +27.5% | 10,751 | +24.6% | 0.01% | +50.0% |
| Q4 2020 | $287,000 | -3.7% | 8,631 | -7.0% | 0.01% | -14.3% |
| Q3 2020 | $298,000 | +9.2% | 9,276 | -6.3% | 0.01% | +16.7% |
| Q2 2020 | $273,000 | – | 9,898 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |